Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp.

Sector: Healthcare   

Industry: Biotechnology

Optionable: Yes  Market Cap: 302 M  90-day average vol: 1,308,967

Previous close: 3.68  Open: 3.71  Bid: 3.4  Ask: 3.41
52 week range    
PTN / 
Last updated: Thursday 25th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


AVXL Income Statement

Basic EPS from continuing operations-0.54-0.6
Basic EPS total-1.16-2.6-0.42-0.54-0.6
Basic weighted shares outstanding10 M5 M35 M41 M45 M49 M58 M70 M80 M
Diluted EPS total-1.2-2.6-0.42-0.33-0.39-0.54-0.45-0.54-0.6
Diluted normalized net income/share-0.45-0.6
Diluted weighted shares outstanding10 M5 M35 M41 M44 M49 M58 M70 M80 M
Fees-9 M-5 M-5812.0-30943.0-151133.0
GeneralAndAdministrativeExpense2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
Gross operating profit-9 M-5 M-5812.0-30943.0-151133.0
Income before tax-11 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-47 M
Income restructuring and M&A-2 M-5 M
Income taxes-1 M5000.029615.059607.072746.082181.022664.0267565.0358000.07000.0
Interest income199655.0924895.02 M2 M3 M5 M
InterestExpenseNonOperating7089.071825.0-179973.0-26261.0-947000.0-7 M
MiscOtherSpecialCharges2 M7 M61205.02 M115758.05 M3 M2 M
Net income from total operations-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetIncomeCommonStockholders-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetIncomeContinuousOperations-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
NetNonOperatingInterestIncomeExpense192566.0-71825.0924895.02 M2 M3 M5 M26261.0947000.07 M
Normalized income-38 M
Operating income-12 M-12 M-16 M-16 M-19 M-29 M-31 M-42 M-51 M-56 M
Operating income before depreciation (EBITDA)-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-49 M-54 M
OperatingExpense-3 M-7 M-16 M-16 M-19 M-29 M31 M-42 M51 M56 M
Other income net-2 M-7 M-61205.0-2 M-115758.0-5 M-3 M-2 M
OtherGandA2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
RentAndLandingFees2 M5 M8 M5 M6 M7 M-233423.0130784.072865.0
Research & development expense732395.02 M7 M11 M13 M22 M25 M33 M38 M44 M
ResearchExpense732395.02 M7 M11 M13 M22 M25 M33 M38 M44 M
RestructringAndMnAIncome-2 M-5 M
SalariesAndWages-413979.0-5 M-4 M-6 M-6 M-5 M18 M16 M
Selling Gen & administrative expense2 M5 M8 M5 M6 M7 M6 M9 M13 M12 M
SellingAndMarketingExpense-1 M-3 M
Special income/charges2 M5 M
Total Income available for interest expense (EBIT)-11 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-49 M-54 M
Total common shares outstanding14 M9 M40 M44 M47 M56 M67 M76 M82 M
Total net income-10 M-12 M-15 M-13 M-17 M-26 M-26 M-38 M-48 M-48 M
Total ordinary shares82 M82 M82 M82 M82 M82 M82 M82 M82 M82 M
Total revenues-9 M-5 M-5812.0-30943.0-151133.0
TotalExpenses-3 M-7 M-16 M-16 M-19 M-29 M31 M-42 M51 M56 M
TotalRevenue-9 M-5 M-5812.0-30943.0-151133.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University